{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:34:26Z","timestamp":1791246866550,"version":"4.1.0"},"reference-count":344,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Commission: Protecting the food chain from prions: shaping European priorities through basic and applied research","award":["FP7-KBBE-2007-2A"],"award-info":[{"award-number":["FP7-KBBE-2007-2A"]}]},{"name":"Neurodegenerative Disease Research","award":["01ED1201A"],"award-info":[{"award-number":["01ED1201A"]}]},{"name":"Neurodegenerative Disease Research","award":["12851"],"award-info":[{"award-number":["12851"]}]},{"name":"Intraciber project 2014: Rapid Dementias"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.pneurobio.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T18:31:11Z","timestamp":1458671471000},"page":"36-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["CSF biomarkers in neurodegenerative and vascular dementias"],"prefix":"10.1016","volume":"138-140","author":[{"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2016.03.003_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnagi.2014.00248","article-title":"Elevated levels of cerebrospinal fluid \u03b1-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers","volume":"6","author":"Aasly","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","article-title":"A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity","volume":"127","author":"Ahmed","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.exger.2012.06.001","article-title":"The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium","volume":"47","author":"Alafuzoff","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","article-title":"Relationship between beta-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer\u2019s disease","volume":"42","author":"Alcolea","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.neurobiolaging.2015.03.001","article-title":"Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer\u2019s disease","volume":"36","author":"Alcolea","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer disease","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp.2009.199950","article-title":"CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson\u2019s disease: the Norwegian ParkWest study","volume":"81","author":"Alves","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0000000000000425","article-title":"CSF Abeta42 predicts early-onset dementia in Parkinson disease","volume":"82","author":"Alves","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00001756-200002070-00013","article-title":"Amyloid Abeta40CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia","volume":"11","author":"Andersen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","article-title":"Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer\u2019s disease: a community based follow up study","volume":"64","author":"Andreasen","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00617-5","article-title":"Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"273","author":"Andreasen","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen","year":"2003","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen","year":"2003","journal-title":"Acta Neurol. Scand. Suppl"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2014.08.004","article-title":"Deregulation of purine metabolism in Alzheimer\u2019s disease","volume":"36","author":"Ansoleaga","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer\u2019s disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/exnr.2000.7501","article-title":"CSF phosphorylated tau protein and mild cognitive impairment: a prospective study","volume":"166","author":"Arai","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000017235","article-title":"Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer\u2019s disease","volume":"11","author":"Armstrong","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nmeth1066","article-title":"Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein","volume":"4","author":"Atarashi","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nmeth0308-211","article-title":"Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking","volume":"5","author":"Atarashi","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/pri.5.3.16893","article-title":"Real-time quaking-induced conversion: a highly sensitive assay for prion detection","volume":"5","author":"Atarashi","year":"2011","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/15672050113109990002","article-title":"Neuropathological correlates of cerebral multimorbidity","volume":"10","author":"Attems","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer\u2019s disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.10.020","article-title":"Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer\u2019s disease","volume":"32","author":"Bekris","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ana.10621","article-title":"Specification of 14-3-3 proteins in Lewy bodies","volume":"54","author":"Berg","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/375698a0","article-title":"Non-genetic propagation of strain-specific properties of scrapie prion protein","volume":"375","author":"Bessen","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0145","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/01.wnl.0000311445.21321.fc","article-title":"CSF biomarkers in frontotemporal lobar degeneration with known pathology","volume":"70","author":"Bian","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000322370","article-title":"Cerebrospinal fluid tau, p-tau 181 and amyloid-beta38\/40\/42 in frontotemporal dementias and primary progressive aphasias","volume":"31","author":"Bibl","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00702-012-0801-3","article-title":"Cerebrospinal fluid amyloid-beta 2-42 is decreased in Alzheimer\u2019s, but not in frontotemporal dementia","volume":"119","author":"Bibl","year":"2012","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0160","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid","volume":"2010","author":"Bjerke","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02260939","article-title":"Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?","volume":"8","author":"Blennow","year":"1994","journal-title":"J. Neural Trans. Park Dis. Dement. Sect."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer\u2019s disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0185","first-page":"1147","article-title":"Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease","volume":"16","author":"Blennow","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","article-title":"Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease","volume":"1","author":"Blennow","year":"2004","journal-title":"NeuroRx."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000216841","article-title":"Rapid progression from mild cognitive impairment to Alzheimer\u2019s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4\/epsilon4 genotype","volume":"27","author":"Blom","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0205","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbadis.2004.06.018","article-title":"Tau alteration and neuronal degeneration in tauopathies: mechanisms and models","volume":"1739","author":"Brandt","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2013.03.019","article-title":"Soluble amyloid precursor protein alpha and beta in CSF in Alzheimer\u2019s disease","volume":"1513","author":"Brinkmalm","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1750-1326-9-53","article-title":"SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease","volume":"9","author":"Brinkmalm","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0896-6273(00)80948-4","article-title":"Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function","volume":"19","author":"Broadie","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neurobiolaging.2014.07.043","article-title":"Correlation between decreased CSF alpha-synuclein and Abeta(1)(\u2212)(4)(2) in Parkinson disease","volume":"36","author":"Buddhala","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/bmb\/66.1.121","article-title":"Neuropathology of prion diseases","volume":"66","author":"Budka","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0245","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0250","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"issue":"Suppl. 17","key":"10.1016\/j.pneurobio.2016.03.003_bib0255","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1002\/mds.21677","article-title":"Cognitive dysfunction and dementia in Parkinson disease","volume":"22","author":"Caballol","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/pri.4.2.11756","article-title":"Reduction of PrP(C) in human cerebrospinal fluid after spinal cord injury","volume":"4","author":"Carnini","year":"2010","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nmeth.1465","article-title":"Estimating prion concentration in fluids and tissues by quantitative PMCA","volume":"7","author":"Chen","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fneur.2015.00143","article-title":"Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: the issue of diurnal variation","volume":"6","author":"Cicognola","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0275","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00001756-199301000-00017","article-title":"Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study","volume":"4","author":"Clinton","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0285","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer\u2019s disease features distinct structures of amyloid-beta","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0290","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ane.12441","article-title":"CSF tau correlates with CJD disease severity and cognitive decline","volume":"133","author":"Cohen","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0295","doi-asserted-by":"crossref","first-page":"a006833","DOI":"10.1101\/cshperspect.a006833","article-title":"Prions","volume":"3","author":"Colby","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0300","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00415-014-7560-z","article-title":"Correlates of cerebrospinal fluid levels of oligomeric- and total-\u03b1-synuclein in premotor, motor and dementia stages of Parkinson\u2019s disease","volume":"262","author":"Compta","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nm.3809","article-title":"Understanding biomarkers of neurodegeneration: novel approaches to detecting tau pathology","volume":"21","author":"Cook","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0310","first-page":"339","article-title":"Imbalances of trace elements related to oxidative damage in Alzheimer\u2019s disease brain","volume":"19","author":"Cornett","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0315","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0320","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease","author":"Cramm","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0325","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","article-title":"Characteristic CSF prion seeding efficiency in humans with prion diseases","volume":"51","author":"Cramm","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/089198878800100106","article-title":"Intellectual impairment in Parkinson\u2019s disease: clinical, pathologic, and biochemical correlates","volume":"1","author":"Cummings","year":"1988","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0335","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid","volume":"7","author":"Czech","year":"2012","journal-title":"PLoS. One."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0340","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1523\/JNEUROSCI.0305-12.2012","article-title":"Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels","volume":"32","author":"Damoiseaux","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0345","series-title":"Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders","author":"Dickson","year":"2011"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and creutzfeldt-jakob disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0355","article-title":"Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study","author":"Durrenberger","year":"2014","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/2051-5960-1-75","article-title":"Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation","volume":"1","author":"ElAli","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0375","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.2000.tb06373.x","article-title":"Which vascular lesions are of importance in vascular dementia?","volume":"903","author":"Esiri","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0380","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0390","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer\u2019s disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0395","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","article-title":"Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology","volume":"68","author":"Fagan","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0400","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/21678421.2014.905606","article-title":"Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases:Amyotroph","volume":"15","author":"Feneberg","year":"2014","journal-title":"Lateral. Scler. Frontotemporal. Degener."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/nbdi.1998.0226","article-title":"Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease","volume":"6","author":"Ferrer","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0410","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0306-4522(00)00045-2","article-title":"Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease","volume":"97","author":"Ferrer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0415","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","article-title":"Neurochemistry and the non-motor aspects of PD","volume":"46","author":"Ferrer","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0420","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14734220260418448","article-title":"Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease","volume":"1","author":"Ferrer","year":"2002","journal-title":"Cerebellum"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","article-title":"Early involvement of the cerebral cortex in Parkinson\u2019s disease: convergence of multiple metabolic defects","volume":"88","author":"Ferrer","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0430","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2010.08.039","article-title":"Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin","volume":"299","author":"Ferrer","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0435","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia","volume":"97","author":"Ferrer","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0440","series-title":"Neuropathology of Neurodegenerative Diseases","first-page":"274","article-title":"Concomitant pathologies: cerebrovascular diseases","author":"Ferrer","year":"2015"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0445","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01318865","article-title":"Free - and -amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects","volume":"15","author":"Fisher","year":"1998","journal-title":"Amino. Acids"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0450","first-page":"2010","article-title":"CSF biomarkers profile in CADASIL-A model of pure vascular dementia: usefulness in differential diagnosis in the dementia disorder","author":"Formichi","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0455","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2005.08.007","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid in mitochondrial encephalopathy with lactic acidosis and stroke-like episodes","volume":"239","author":"Fujii","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0465","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1096\/fj.09-150359","article-title":"High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients","volume":"24","author":"Fukumoto","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0470","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2011-110515","article-title":"Decreased sAbetaPPbeta, Abeta38, and Abeta40 cerebrospinal fluid levels in frontotemporal dementia","volume":"26","author":"Gabelle","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0475","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0480","doi-asserted-by":"crossref","first-page":"e15725","DOI":"10.1371\/journal.pone.0015725","article-title":"Abeta40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer\u2019s disease","volume":"5","author":"Gao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0485","article-title":"Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis","author":"Gao","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0490","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/nan.12221","article-title":"Purine metabolism gene deregulation in Parkinson\u2019s disease","volume":"41","author":"Garcia-Esparcia","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-130455","article-title":"Subtype-specific synaptic proteome alterations in sporadic Creutzfeldt-Jakob disease","volume":"37","author":"Gawinecka","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0500","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fneur.2013.00160","article-title":"Tangles, toxicity, and tau secretion in AD\u2014new approaches to a vexing Problem","volume":"4","author":"Gendreau","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0505","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1073\/pnas.0409336102","article-title":"Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer\u2019s disease","volume":"102","author":"Georganopoulou","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.21430","article-title":"Rapidly progressive dementia","volume":"64","author":"Geschwind","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0515","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0520","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","article-title":"14-3-3CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes","volume":"30","author":"Gmitterova","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0525","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","article-title":"14-3-3CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes","volume":"30","author":"Gmitterova","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0530","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0925-4439(00)00043-0","article-title":"Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer\u2019s disease","volume":"1502","author":"Golde","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0535","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","article-title":"Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease","volume":"70","author":"Green","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0540","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.20477","article-title":"Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer\u2019s disease","volume":"57","author":"Grossman","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0545","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0550","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0555","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000077170","article-title":"Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia","volume":"17","author":"Hampel","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0560","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","article-title":"Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study","volume":"61","author":"Hampel","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0565","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer\u2019s disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0570","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0575","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-010-0766-y","article-title":"Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, alpha synuclein and Abeta pathology","volume":"120","author":"Head","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0580","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0585","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-015-0161-y","article-title":"Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer\u2019s disease","volume":"7","author":"Hellwig","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0590","doi-asserted-by":"crossref","first-page":"e105000","DOI":"10.1371\/journal.pone.0105000","article-title":"CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease","volume":"9","author":"Hermann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0595","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ageing\/28.1.39","article-title":"The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson\u2019s disease by use of the CAMCOG neuropsychological test","volume":"28","author":"Hobson","year":"1999","journal-title":"Age Ageing"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0600","doi-asserted-by":"crossref","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","article-title":"Proteopathic tau seeding predicts tauopathy in vivo","volume":"111","author":"Holmes","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0605","doi-asserted-by":"crossref","first-page":"e66381","DOI":"10.1371\/journal.pone.0066381","article-title":"Evaluating amyloid-beta oligomers in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease","volume":"8","author":"Holtta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0610","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mrm.21118","article-title":"Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer\u2019s disease patients","volume":"57","author":"House","year":"2007","journal-title":"Magn Reson. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0615","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e318200d78d","article-title":"Novel CSF biomarkers for frontotemporal lobar degenerations","volume":"75","author":"Hu","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0620","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0625","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer\u2019s disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0630","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/ac301243k","article-title":"Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis-mass spectrometry metabolomics","volume":"84","author":"Ibanez","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0635","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-4933-6-13","article-title":"Pathophysiology of vascular dementia","volume":"6","author":"Iemolo","year":"2009","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0640","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0645","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2007.01.045","article-title":"Neuropathological evaluation of mixed dementia","volume":"257","author":"Jellinger","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0650","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000113679","article-title":"Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0655","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0660","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-7091-6846-2_11","article-title":"Amyloid beta-peptide and its relationship with dementia in Lewy body disease","volume":"51","author":"Jendroska","year":"1997","journal-title":"J. Neural Trans. Suppl"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0665","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356","volume":"274","author":"Jensen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0670","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0675","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","article-title":"Metabolomics of human brain aging and age-related neurodegenerative diseases","volume":"73","author":"Jove","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0680","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0685","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0690","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","article-title":"Metabolomics: a global biochemical approach to drug response and disease","volume":"48","author":"Kaddurah-Daouk","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0695","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease","volume":"7","author":"Kaddurah-Daouk","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0700","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer\u2019s disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0705","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","article-title":"Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease, vascular dementia and ischemic stroke patients: a critical analysis","volume":"260","author":"Kaerst","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0710","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","article-title":"Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease, vascular dementia and ischemic stroke patients: a critical analysis","volume":"260","author":"Kaerst","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0715","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-130995","article-title":"Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson\u2019s disease, and Alzheimer\u2019s disease","volume":"38","author":"Kaerst","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0720","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1212\/WNL.54.9.1875","article-title":"Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies","volume":"54","author":"Kanemaru","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0725","first-page":"1277","article-title":"Association of cerebrospinal fluid beta-amyloid 1-42, T-tauP-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0730","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer\u2019s disease?","volume":"71","author":"Kapaki","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0735","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.neurobiolaging.2015.01.021","article-title":"Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease","volume":"36","author":"Karch","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0740","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.neurobiolaging.2015.01.021","article-title":"Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease","volume":"36","author":"Karch","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0745","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","article-title":"Increased alpha-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"261","author":"Kasai","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0750","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","article-title":"14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains","volume":"61","author":"Kawamoto","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0755","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0760","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort","volume":"7","author":"Kester","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0765","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130932","article-title":"MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer\u2019s disease","volume":"39","author":"Kiko","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0770","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/BCR.0b013e3182642bf8","article-title":"Human red blood cells contain antifibrogenic factors that stimulate MMP-1 expression in dermal fibroblasts","volume":"34","author":"Kilani","year":"2013","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0775","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jalz.2011.12.007","article-title":"Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia","volume":"9","author":"Koedam","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0780","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","article-title":"Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"287","author":"Kohnken","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"Suppl. A","key":"10.1016\/j.pneurobio.2016.03.003_bib0785","first-page":"69","article-title":"Contribution of neuropathology to the understanding of human prion disease","volume":"42","author":"Kovacs","year":"2004","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0790","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe consortium experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement. Geriatr. Cogn Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0795","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe consortium experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement. Geriatr. Cogn Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0800","series-title":"Neuropathology of Neurodegenerative Diseases","first-page":"292","article-title":"Concomitant pathologies II: neurodegenerative conditions","author":"Kovacs","year":"2015"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0805","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000095159","article-title":"Familial occurrence of dementia and parkinsonism: a systematic review","volume":"22","author":"Kurz","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0810","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0815","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer\u2019s disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0820","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(96)12598-2","article-title":"Neurofibrillary tangles of Alzheimer\u2019s disease brains contain 14-3-3 proteins","volume":"209","author":"Layfield","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0825","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0830","first-page":"203","article-title":"Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease","volume":"72","author":"Lehallier","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0835","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.55.4.514","article-title":"14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients","volume":"55","author":"Lemstra","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0840","first-page":"CR484","article-title":"Total tau in cerebrospinal fluid differentiates Alzheimer\u2019s disease from vascular dementia","volume":"9","author":"Leszek","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0845","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.parkreldis.2010.10.003","article-title":"Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson\u2019s disease","volume":"17","author":"Leverenz","year":"2011","journal-title":"Parkinsonism. Relat Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0850","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI25410","article-title":"Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model","volume":"116","author":"Levites","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0855","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/rcm.1048","article-title":"The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer\u2019s disease: evidence of a novel carboxyterminally elongated Abeta peptide","volume":"17","author":"Lewczuk","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0860","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","article-title":"Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF Abeta42 Abeta42\/Abeta40 ratio and total tau","volume":"25","author":"Lewczuk","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0865","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/mp.2008.84","article-title":"Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer\u2019s disease: a multicenter study","volume":"15","author":"Lewczuk","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0870","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","article-title":"Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies","volume":"131","author":"Lewis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0875","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0880","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/srep01339","article-title":"Ratio of Abeta42\/P-tau181p in CSF is associated with aberrant default mode network in AD","volume":"3","author":"Li","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0885","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/joim.12164","article-title":"The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer\u2019s disease","volume":"275","author":"Li","year":"2014","journal-title":"J. Intern. Med."},{"issue":"Suppl. B","key":"10.1016\/j.pneurobio.2016.03.003_bib0890","first-page":"39","article-title":"An outline of the neuropathology of transmissible spongiform encephalopathies (prion diseases)","volume":"42","author":"Liberski","year":"2004","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0895","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.parkreldis.2013.06.008","article-title":"The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies\u2014a systematic review and meta-analysis","volume":"19","author":"Lim","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0900","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1515\/CCLM.2006.073","article-title":"Preanalytical variability: the dark side of the moon in laboratory testing","volume":"44","author":"Lippi","year":"2006","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0905","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/Abeta42 predict cognitive decline in Parkinson\u2019s disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0910","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/pri.26416","article-title":"PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2","volume":"7","author":"Llorens","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0915","article-title":"Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease","author":"Llorens","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0920","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00415-015-7837-x","article-title":"Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD","volume":"262","author":"Llorens","year":"2015","journal-title":"J. Neurol ."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0925","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","article-title":"Increased albumin CSF\/serum ratio in dementia with Lewy bodies","volume":"358","author":"Llorens","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2015.10.009","article-title":"Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia","author":"Llorens","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0935","series-title":"Greenfield\u2019s Neuropathology","author":"Love","year":"2015"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0940","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0945","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10048-007-0102-4","article-title":"The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments","volume":"8","author":"Mackenzie","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0950","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1038\/tp.2015.52","article-title":"d-serine levels in Alzheimer\u2019s disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0955","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/cdd.2015.79","article-title":"Fibril growth and seeding capacity play key roles in alpha-synuclein-mediated apoptotic cell death","volume":"22","author":"Mahul-Mellier","year":"2015","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0960","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0965","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-8-38","article-title":"Blood-brain-barriers in aging and in Alzheimer\u2019s disease","volume":"8","author":"Marques","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0970","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/pri.19806","article-title":"Prion infection promotes extensive accumulation of alpha-synuclein in aged human alpha-synuclein transgenic mice","volume":"6","author":"Masliah","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0975","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2377-11-120","article-title":"High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease","volume":"11","author":"Matsui","year":"2011","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0980","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"Mattsson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0985","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer\u2019s association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib0990","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamaneurol.2014.4530","article-title":"Predicting reduction of cerebrospinal fluid beta-amyloid 42 in cognitively healthy controls","volume":"72","author":"Mattsson","year":"2015","journal-title":"JAMA Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2016.03.003_bib0995","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","article-title":"alpha-Synucleinopathy phenotypes","volume":"20","author":"McCann","year":"2014","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1000","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1005","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2353\/ajpath.2007.070051","article-title":"Transdifferentiation of peripheral blood mononuclear cells into epithelial-like cells","volume":"171","author":"Medina","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-010-5738-6","article-title":"Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel","volume":"258","author":"Meiner","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-2009-1110","article-title":"Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders","volume":"17","author":"Meyne","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000083178","article-title":"Tau protein Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"19","author":"Mollenhauer","year":"2005","journal-title":"Dement. Geriatr. Cogn Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.pneurobio.2016.03.003_bib1045","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S1353-8020(13)70020-8","article-title":"Quantification of alpha-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson\u2019s disease?","volume":"20","author":"Mollenhauer","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1050","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nprot.2012.067","article-title":"Protein misfolding cyclic amplification of infectious prions","volume":"7","author":"Morales","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1055","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1021\/bi400866w","article-title":"Conformational features of tau fibrils from Alzheimer\u2019s disease brain are faithfully propagated by unmodified recombinant protein","volume":"52","author":"Morozova","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2051-5960-1-28","article-title":"Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer\u2019s disease from normal cognitive aging","volume":"1","author":"Motsinger-Reif","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000141039","article-title":"Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes","volume":"26","author":"Mukaetova-Ladinska","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1070","first-page":"536538","article-title":"Cerebrospinal fluid biomarkers for dementia with lewy bodies","volume":"2010","author":"Mukaetova-Ladinska","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","article-title":"MicroRNAs in Alzheimer\u2019s disease: differential expression in hippocampus and cell-free cerebrospinal fluid","volume":"35","author":"Muller","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000066023","article-title":"Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer\u2019s disease and vascular dementia","volume":"14","author":"Nagga","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1085","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1090","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/brain\/awp214","article-title":"A new subtype of frontotemporal lobar degeneration with FUS pathology","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-009-0581-5","article-title":"Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease","volume":"118","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.11.055","article-title":"CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"1251","author":"Noguchi-Shinohara","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1105","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1074\/jbc.M207880200","article-title":"14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax","volume":"278","author":"Nomura","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353442","article-title":"Evaluation of the cerebrospinal fluid amyloid-beta1-42\/amyloid-beta1-40 ratio measured by alpha-LISA to distinguish Alzheimer\u2019s disease from other dementia disorders","volume":"36","author":"Nutu","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12916-014-0218-y","article-title":"Vascular risk factors and Alzheimer\u2019s disease","volume":"12","author":"O\u2019Brien","year":"2014","journal-title":"BMC. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","article-title":"Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?","volume":"450","author":"Ohrfelt","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","article-title":"Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients","volume":"183","author":"Olsson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-4159.2011.07187.x","article-title":"Low-n oligomers as therapeutic targets of Alzheimer\u2019s disease","volume":"117","author":"Ono","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orru","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1140","doi-asserted-by":"crossref","first-page":"e1004983","DOI":"10.1371\/journal.ppat.1004983","article-title":"Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains","volume":"11","author":"Orru","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1468-1331.2008.02387.x","article-title":"CSF biomarker profile and diagnostic value in vascular dementia","volume":"16","author":"Paraskevas","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100720170055","article-title":"CSF phosphorylated tau is a possible marker for discriminating Alzheimer\u2019s disease from dementia with Lewy bodies. Phospho-Tau International Study Group","volume":"22","author":"Parnetti","year":"2001","journal-title":"Neurol. Sci"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1160","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","article-title":"Cerebrospinal fluid Tau\/alpha-synuclein ratio in Parkinson\u2019s disease and degenerative dementias","volume":"26","author":"Parnetti","year":"2011","journal-title":"Mov Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson\u2019s Disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000099473","article-title":"CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer\u2019s disease and controls","volume":"23","author":"Pijnenburg","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jnnp.2006.105064","article-title":"Decreased cerebrospinal fluid amyloid beta (1\u201340) levels in frontotemporal lobar degeneration","volume":"78","author":"Pijnenburg","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1180","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nm0798-832","article-title":"Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer\u2019s patients by fluorescence correlation spectroscopy","volume":"4","author":"Pitschke","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1185","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1515\/CCLM.2006.123","article-title":"Errors in clinical laboratories or errors in laboratory medicine?","volume":"44","author":"Plebani","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23955","article-title":"Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease","volume":"74","author":"Podlesniy","year":"2013","journal-title":"Ann. Neurol."},{"issue":"21 (January)","key":"10.1016\/j.pneurobio.2016.03.003_bib1195","first-page":"S1552","article-title":"Mitochondrial DNA differentiates Alzheimer from Creutzfeldt-Jakob disease","volume":"15","author":"Podlesniy","year":"2016","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1200","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer\u2019s disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1205","doi-asserted-by":"crossref","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","article-title":"Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers","volume":"5","author":"Potter","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2011.07574.x","article-title":"Seeding plaques in Alzheimer\u2019s disease","volume":"120","author":"Prado","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","article-title":"Biology and genetics of prions causing neurodegeneration","volume":"47","author":"Prusiner","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1533317507310565","article-title":"Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies","volume":"23","author":"Revuelta","year":"2008","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00401-002-0642-5","article-title":"Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies","volume":"105","author":"Richard","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1235","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","article-title":"Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration","volume":"58","author":"Riemenschneider","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","article-title":"Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias","volume":"8","author":"Riemenschneider","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1245","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awu190","article-title":"Perforant path synaptic loss correlates with cognitive impairment and Alzheimer\u2019s disease in the oldest-old","volume":"137","author":"Robinson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1250","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1255","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1471-4159.2011.07551.x","article-title":"Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats","volume":"120","author":"Rosen","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1260","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000381828","article-title":"Cerebrospinal fluid biomarkers in familial forms of Alzheimer\u2019s disease and frontotemporal dementia","volume":"40","author":"Rostgaard","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1265","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","article-title":"Interactions between Tau and alpha-synuclein augment neurotoxicity in a Drosophila model of Parkinson\u2019s disease","volume":"23","author":"Roy","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1270","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1275","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1212\/01.wnl.0000437306.37850.22","article-title":"Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease","volume":"81","author":"Sala","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.celrep.2014.02.031","article-title":"Detection of misfolded Abeta oligomers for sensitive biochemical diagnosis of Alzheimer\u2019s disease","volume":"7","author":"Salvadores","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1285","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/gps.2353","article-title":"Cerebrospinal fluid total tau as a marker of Alzheimer\u2019s disease intensity","volume":"25","author":"Samgard","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1290","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1295","doi-asserted-by":"crossref","first-page":"e54915","DOI":"10.1371\/journal.pone.0054915","article-title":"Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay","volume":"8","author":"Sano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2012-111361","article-title":"Amyloid-beta oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer\u2019s disease","volume":"29","author":"Santos","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1305","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/labinvest.2009.68","article-title":"Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease","volume":"90","author":"Satoh","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-014-0072-3","article-title":"Biomarkers in biological fluids for dementia with Lewy bodies","volume":"6","author":"Schade","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2990.2008.00952.x","article-title":"Review: Familial Parkinson\u2019s disease\u2013genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease","volume":"34","author":"Schiesling","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000278692","article-title":"Clinical features of rapidly progressive Alzheimer\u2019s disease","volume":"29","author":"Schmidt","year":"2010","journal-title":"Dement. Geriatr. Cogn Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1325","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly progressive Alzheimer disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1330","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly progressive Alzheimer disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1335","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","article-title":"Rapidly progressive Alzheimer\u2019s disease: a multicenter update","volume":"30","author":"Schmidt","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1340","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","article-title":"Rapidly progressive Alzheimer\u2019s disease: a multicenter update","volume":"30","author":"Schmidt","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1345","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/j.1460-9568.2010.07224.x","article-title":"Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease","volume":"31","author":"Schmitz","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1350","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2013.11.010","article-title":"Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases","volume":"35","author":"Schmitz","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1355","article-title":"Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic","author":"Schmitz","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1360","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neurobiolaging.2015.05.013","article-title":"Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy","volume":"36","author":"Schmitz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1365","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1161\/STROKEAHA.110.598326","article-title":"Where vascular meets neurodegenerative disease","volume":"41","author":"Schneider","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1370","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1375","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.20508","article-title":"Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?","volume":"58","author":"Schoonenboom","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1385","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review","volume":"82","author":"Seelaar","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1390","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","article-title":"CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings","volume":"78","author":"Seppala","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1395","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/PL00012495","article-title":"Functions and malfunctions of the tau proteins","volume":"59","author":"Shahani","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1400","doi-asserted-by":"crossref","first-page":"564534","DOI":"10.1155\/2013\/564534","article-title":"Neuroprotective function of 14-3-3 proteins in neurodegeneration","volume":"2013","author":"Shimada","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1405","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1410","doi-asserted-by":"crossref","first-page":"e28938","DOI":"10.1371\/journal.pone.0028938","article-title":"Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage","volume":"6","author":"Siman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1415","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s007020070079","article-title":"CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging","volume":"107","author":"Sjogren","year":"2000","journal-title":"J. Neural. Trans."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer\u2019s disease","volume":"70","author":"Sjogren","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1425","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1430","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry","volume":"71","author":"Skillback","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000068478","article-title":"Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds","volume":"15","author":"Skoog","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1440","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.jalz.2013.10.004","article-title":"Increased CSF alpha-synuclein levels in Alzheimer\u2019s disease: correlation with tau levels","volume":"10","author":"Slaets","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1445","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease","author":"Snyder","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1450","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2009-0955","article-title":"Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders","volume":"16","author":"Spies","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1455","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/156720510791383796","article-title":"The cerebrospinal fluid amyloid beta42\/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia","volume":"7","author":"Spies","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1465","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-015-1413-4","article-title":"Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice","volume":"129","author":"Stancu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2005.05.016","article-title":"AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis","volume":"237","author":"Stefani","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1475","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1480","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1485","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-014-0170-y","article-title":"Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer\u2019s disease and multiple sclerosis","volume":"11","author":"Stoeck","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2004.11.013","article-title":"Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes","volume":"27","author":"Strekalova","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1495","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1500","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/alzrt262","article-title":"beta-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP\/PS1 transgenic mice","volume":"6","author":"Sudduth","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1505","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1510","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.07.015","article-title":"Assessment of CSF Abeta42 as an aid to discriminating Alzheimer\u2019s disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies","volume":"345","author":"Tang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1515","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00702-014-1226-y","article-title":"Does CSF p-tau181 help to discriminate Alzheimer\u2019s disease from other dementias and mild cognitive impairment? A meta-analysis of the literature","volume":"121","author":"Tang","year":"2014","journal-title":"J. Neural. Trans."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1520","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1097\/00001756-199712220-00022","article-title":"The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer\u2019s disease","volume":"8","author":"Tapiola","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1525","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1530","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamaneurol.2015.0202","article-title":"Cerebrospinal fluid markers of neurodegeneration and rates of brain atrophy in early Alzheimer disease","volume":"72","author":"Tarawneh","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2010\/635053","article-title":"Standardization of assay procedures for analysis of the csf biomarkers amyloid beta((1-42)), tau, and phosphorylated tau in Alzheimer\u2019s disease: report of an international workshop","volume":"2010","author":"Teunissen","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1540","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3233\/JAD-140339","article-title":"Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer\u2019s disease","volume":"43","author":"Thordardottir","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1545","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1550","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1555","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","article-title":"Observations on the brains of demented old people","volume":"11","author":"Tomlinson","year":"1970","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1560","doi-asserted-by":"crossref","first-page":"e36159","DOI":"10.1371\/journal.pone.0036159","article-title":"Altered prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease","volume":"7","author":"Torres","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1565","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","article-title":"Advances in the genetics of Parkinson disease","volume":"9","author":"Trinh","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1570","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s Disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1575","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1580","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00019442-200403000-00009","article-title":"Familial occurrence of dementia with Lewy bodies","volume":"12","author":"Tsuang","year":"2004","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1585","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5414\/NP300796","article-title":"Detection of disease-associated alpha-synuclein in the cerebrospinal fluid: a feasibility study","volume":"33","author":"Unterberger","year":"2014","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JAD-1999-1606","article-title":"Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients","volume":"1","author":"Van","year":"1999","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1595","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jnnp.73.1.79","article-title":"Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease","volume":"73","author":"Van","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1600","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease","volume":"74","author":"Van","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1605","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s biomarkers standardization initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1610","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1615","doi-asserted-by":"crossref","first-page":"e0135458","DOI":"10.1371\/journal.pone.0135458","article-title":"The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies","volume":"10","author":"Wennstrom","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1620","doi-asserted-by":"crossref","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1625","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1630","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1635","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.0000000000001399","article-title":"Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI","volume":"84","author":"Wolfsgruber","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1640","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.872","article-title":"Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease","volume":"194","author":"Wong","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1645","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1242\/jcs.126102","article-title":"14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes","volume":"126","author":"Xu","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1650","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(95)90118-3","article-title":"Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease","volume":"345","author":"Zerr","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1655","first-page":"874","article-title":"The 14-3-3 brain protein and transmissible spongiform encephalopathy","volume":"336","author":"Zerr","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1660","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1665","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1670","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archneur.63.9.1277","article-title":"Neurochemical aftermath of amateur boxing","volume":"63","author":"Zetterberg","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1675","first-page":"1","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","author":"Zetterberg","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1680","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","article-title":"Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)","volume":"87","author":"Zha","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1685","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-150064","article-title":"Super-resolution microscopy of cerebrospinal fluid biomarkers as a tool for Alzheimer\u2019s disease diagnostics","author":"Zhang","year":"2015","journal-title":"J. Alzheimers. Dis"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1690","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1196\/annals.1379.012","article-title":"Imaging and CSF studies in the preclinical diagnosis of Alzheimer\u2019s disease","volume":"1097","author":"de Leon","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1695","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/gerona\/61.7.755","article-title":"Cerebrospinal fluid amyloid beta42\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia","volume":"61","author":"de","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1700","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1705","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"del","year":"2012","journal-title":"Biomark. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1710","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/CCLM.2011.086","article-title":"Tau and p-tau as CSF biomarkers in dementia: a meta-analysis","volume":"49","author":"van Harten","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1715","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/bies.1134","article-title":"14-3-3 proteins: key regulators of cell division, signalling and apoptosis","volume":"23","author":"van Hemert","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.pneurobio.2016.03.003_bib1720","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbadis.2011.07.003","article-title":"Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction","volume":"1822","author":"van Norden","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008216300028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T16:41:41Z","timestamp":1600360901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008216300028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":344,"alternative-id":["S0301008216300028"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.003","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF biomarkers in neurodegenerative and vascular dementias","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}